Filing Details

Accession Number:
0001493152-25-006632
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
SB Investment Advisers (UK) Limited
Company:
Roivant Sciences Ltd.
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
SB Investment Advisers (UK) Limited 0 62,057,537 8.5%
SoftBank Vision Fund L.P. 0 62,057,537 8.5%
SVF Holdings (UK) LLP 0 62,057,537 8.5%
SVF Investments (UK) Limited 0 62,057,537 8.5%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
SB Investment Advisers (UK) Limited
 
Signature:/s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/14/2025
 
SoftBank Vision Fund L.P.
 
Signature:By: SB Investment Advisers (UK) Limited, its Manager, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/14/2025
 
SVF Holdings (UK) LLP
 
Signature:By: SoftBank Vision Fund L.P., its Managing Member, By: SB Investment Advisers (UK) Limited, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/14/2025
 
SVF Investments (UK) Limited
 
Signature:By: SVF Holdings (UK) LLP, its Sole Owner, By: SoftBank Vision Fund L.P., By: SB Investment Advisers (UK) Limited, /s/ Amanda Sanchez-Barry
Name/Title:Amanda Sanchez-Barry, General Counsel
Date:02/14/2025
Exhibit Information

Joint Filing Agreement (previously filed).